From: Clinical pattern of synthetic cannabinoids users in Upper Egypt: cross-sectional study
Number N = 50 | Percentage (%) | |
---|---|---|
Neuro-psychiatric effects | ||
Dizziness/Drowsiness | 34 | 68% |
Headache | 11 | 22% |
Seizures | 4 | 8% |
Irritability/agitation | 2 | 4% |
Auditory and visual hallucination | 29 | 58% |
Auditory only hallucination | 2 | 4% |
Panic attack (fear of death) | 13 | 26% |
Psychosis | 1 | 2% |
Cardiovascular effects | ||
Palpitation | 38 | 76% |
Chest Pain | 6 | 12% |
Gastrointestinal effect | ||
Nausea and vomiting | 12 | 24% |
Others | ||
Blurred vision and red eye | 44 | 88% |
Withdrawal manifestation | 10 | 20% |
No symptoms were experienced | 2 | 4% |